首页> 美国卫生研究院文献>BMJ Open >Protocol for a phase III randomised trial of image-guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy for late small bowel toxicity reduction after postoperative adjuvant radiation in Ca cervix
【2h】

Protocol for a phase III randomised trial of image-guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy for late small bowel toxicity reduction after postoperative adjuvant radiation in Ca cervix

机译:宫颈癌术后辅助放疗后影像引导强度调制放疗(IG-IMRT)和常规放疗用于晚期小肠毒性降低的III期随机试验方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionExternal beam radiation followed by vaginal brachytherapy (±chemotherapy) leads to reduction in the risk of local recurrence and improves progression-free survival in patients with adverse risk factors following Wertheim's hysterectomy albeit at the risk of late bowel toxicity. Intensity Modulated Radiotherapy (IMRT) results in reduction in bowel doses and has potential to reduce late morbidity, however, needs to be confirmed prospectively in a randomised trial. The present randomised trial tests reduction if any in late small bowel toxicity with the use of IMRT in postoperative setting.
机译:引言体外射线束治疗后再进行阴道近距离放射疗法(±化学疗法)可以降低发生Wertheim子宫切除术后有不良危险因素的患者局部复发的风险,并改善无进展生存,尽管存在晚期肠毒性的风险。调强放疗(IMRT)可以减少肠道剂量,并具有降低晚期发病率的潜力,但是,需要在一项随机试验中进行前瞻性确认。目前的随机试验测试在术后环境中使用IMRT可以减少晚期小肠毒性(如果有)。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号